Wyrwicz L, Dechaphunkul A, Lee JS, Turpin A, et al. A Randomized, Nivolumab-Controlled, Phase II Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus. Clin Cancer Res 2026;32:4319-4330.
PMID: 42440370